Elevated Expression of Maspin mRNA as a Predictor of Survival in Stage II and III Gallbladder Cancer Cases

Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, wi...

Full description

Saved in:
Bibliographic Details
Published inAsian Pacific journal of cancer prevention : APJCP Vol. 15; no. 1; pp. 343 - 347
Main Authors Baghel, Kavita, Kazmi, Hasan Raza, Raj, Saloni, Chandra, Abhijit, Srivastava, Rajeshwar Nath
Format Journal Article
LanguageEnglish
Published Thailand 01.01.2014
Subjects
Online AccessGet full text
ISSN1513-7368
2476-762X
DOI10.7314/APJCP.2014.15.1.343

Cover

Abstract Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, with particular attention to prognostic importance in individuals with malignancies. This study was carried out at the Department of Surgical Gastroenterology, King George's Medical University, Lucknow, India. Gallbladder samples from normal (n=25), gall stone disease (n=25) and cancer patients (n=38) were analysed for maspin mRNA expression by semi-quantitative reverse transcriptase PCR and quantitative real time PCR. Statistical analysis was carried out using the Students t test or ANOVA. Survival analysis was conducted according to the Kaplan-Meier method and correlations were assessed using the Pearson correlation method. p<0.05 was considered statistically significant. Significant increase (p=0.028) in expression of maspin mRNA was observed in gallbladder cancer as compared to gall stone disease, whereas no expression was found in normal tissues. Significant correlation (Pearson's coefficient(r)=-0.798, p<0.0001) was observed between relative quantification of maspin mRNA and survival of cancer patients after surgery, with significantly shorter (p=0.002) survival in patients having relative quantification >1.5 as compared to those having relative quantification <1.5. Similarly, significant differences in patient survival for maspin mRNA expression was observed for stage II (p=0.025) and III (p=0.011) cancer. Higher expression of maspin mRNA in gallbladder cancer has prognostic significance for stage II and III cancer, which needs to be investigated further.
AbstractList Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, with particular attention to prognostic importance in individuals with malignancies. This study was carried out at the Department of Surgical Gastroenterology, King George's Medical University, Lucknow, India. Gallbladder samples from normal (n=25), gall stone disease (n=25) and cancer patients (n=38) were analysed for maspin mRNA expression by semi-quantitative reverse transcriptase PCR and quantitative real time PCR. Statistical analysis was carried out using the Students t test or ANOVA. Survival analysis was conducted according to the Kaplan-Meier method and correlations were assessed using the Pearson correlation method. p<0.05 was considered statistically significant. Significant increase (p=0.028) in expression of maspin mRNA was observed in gallbladder cancer as compared to gall stone disease, whereas no expression was found in normal tissues. Significant correlation (Pearson's coefficient(r)=-0.798, p<0.0001) was observed between relative quantification of maspin mRNA and survival of cancer patients after surgery, with significantly shorter (p=0.002) survival in patients having relative quantification >1.5 as compared to those having relative quantification <1.5. Similarly, significant differences in patient survival for maspin mRNA expression was observed for stage II (p=0.025) and III (p=0.011) cancer. Higher expression of maspin mRNA in gallbladder cancer has prognostic significance for stage II and III cancer, which needs to be investigated further.
Author Raj, Saloni
Baghel, Kavita
Chandra, Abhijit
Kazmi, Hasan Raza
Srivastava, Rajeshwar Nath
Author_xml – sequence: 1
  givenname: Kavita
  surname: Baghel
  fullname: Baghel, Kavita
– sequence: 2
  givenname: Hasan Raza
  surname: Kazmi
  fullname: Kazmi, Hasan Raza
– sequence: 3
  givenname: Saloni
  surname: Raj
  fullname: Raj, Saloni
– sequence: 4
  givenname: Abhijit
  surname: Chandra
  fullname: Chandra, Abhijit
– sequence: 5
  givenname: Rajeshwar Nath
  surname: Srivastava
  fullname: Srivastava, Rajeshwar Nath
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24528054$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtOwzAURC0Eog_4AiTkH0iw41eyrKJSggpUFCR21k3ioFRpUtlpBX-P29INC1azuDOjO2eEztuuNQjdUBIqRvndZPGYLsKIUB5SEdKQcXaGhhFXMlAy-jhHQyooCxST8QCNnFsRwkWsxCUaRFxEMRF8iFbTxuygNyWefm2sca7uWtxV-Ancpm7x-vV5gsFhwAtryrroO7u_Lrd2V--gwd6y7OHT4CzD0JZeMjyDpskbKEtjcQptcRBn3BW6qKBx5vpXx-j9fvqWPgTzl1mWTuZBwQTpA_-_pIwXuTSJEkVSJTk3LKpiKTgHAUXFWSUVkTxmKo5zSRQwnoPfk-eUEDZGt8fezTZfm1JvbL0G-61Po70hORoK2zlnTaWLuofeL-8t1I2mRO8B6wNgvQesqdBUe8A-y_5kT_X_pX4Asgt8cQ
CitedBy_id crossref_primary_10_1007_s11033_025_10293_w
crossref_primary_10_1155_2014_625695
crossref_primary_10_1111_ajco_13129
crossref_primary_10_1007_s10528_016_9745_x
crossref_primary_10_13105_wjma_v7_i4_142
Cites_doi 10.1111/j.1477-2574.2010.00255.x
10.1159/000353133
10.1093/ije/18.1.50
10.3816/CLC.2008.n.052
10.7314/APJCP.2012.13.1.187
10.1097/CEJ.0b013e3280145e1b
10.1126/science.8290962
10.1245/s10434-010-0985-4
10.1002/path.1319
10.1002/jso.20526
10.1007/s13277-010-0056-2
10.1002/ijc.21683
10.1016/S1470-2045(03)01021-0
10.1371/journal.pone.0063581
10.1159/000132570
10.1111/j.1440-1746.2004.03355.x
10.1159/000084525
10.1186/2001-1326-2-8
10.1001/jama.1983.03340170049027
10.1023/A:1010652105532
10.1136/jcp.2005.027284
10.1038/sj.onc.1203535
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.7314/APJCP.2014.15.1.343
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2476-762X
EndPage 347
ExternalDocumentID 24528054
10_7314_APJCP_2014_15_1_343
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
.UV
23N
2WC
53G
5GY
9ZL
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
CITATION
E3Z
EBS
EJD
F5P
FRJ
GROUPED_DOAJ
GX1
JDI
OK1
OVT
RPM
TR2
W2D
WOW
CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-c350t-4766134cb6e975c9f9b4e32f86544a5acf43f6706483788b607a34ba805bb1003
ISSN 1513-7368
IngestDate Sat Sep 18 02:45:52 EDT 2021
Tue Jul 01 04:31:26 EDT 2025
Thu Apr 24 23:02:48 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c350t-4766134cb6e975c9f9b4e32f86544a5acf43f6706483788b607a34ba805bb1003
OpenAccessLink http://society.kisti.re.kr/sv/SV_svpsbs03V.do?method=download&cn1=JAKO201417638007898
PMID 24528054
PageCount 5
ParticipantIDs pubmed_primary_24528054
crossref_citationtrail_10_7314_APJCP_2014_15_1_343
crossref_primary_10_7314_APJCP_2014_15_1_343
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Thailand
PublicationPlace_xml – name: Thailand
PublicationTitle Asian Pacific journal of cancer prevention : APJCP
PublicationTitleAlternate Asian Pac J Cancer Prev
PublicationYear 2014
References (POCPA9_2014_v15n1_343_015) 2003; 199
(POCPA9_2014_v15n1_343_027) 1994; 263
(POCPA9_2014_v15n1_343_006) 2012; 5
(POCPA9_2014_v15n1_343_011) 1989; 18
(POCPA9_2014_v15n1_343_012) 2001; 7
(POCPA9_2014_v15n1_343_022) 2011; 13
(POCPA9_2014_v15n1_343_003) 1999; 18
(POCPA9_2014_v15n1_343_016) 2001; 46
(POCPA9_2014_v15n1_343_010) 2006; 93
(POCPA9_2014_v15n1_343_013) 2006; 59
(POCPA9_2014_v15n1_343_023) 2005; 71
POCPA9_2014_v15n1_343_002
(POCPA9_2014_v15n1_343_017) 2006; 118
(POCPA9_2014_v15n1_343_019) 2004; 19
(POCPA9_2014_v15n1_343_014) 2003; 4
(POCPA9_2014_v15n1_343_009) 2008; 29
(POCPA9_2014_v15n1_343_021) 2008; 9
(POCPA9_2014_v15n1_343_005) 2010; 17
(POCPA9_2014_v15n1_343_007) 2013; 30
(POCPA9_2014_v15n1_343_026) 2000; 38
(POCPA9_2014_v15n1_343_004) 1983; 250
(POCPA9_2014_v15n1_343_020) 2002; 8
(POCPA9_2014_v15n1_343_001) 2013; 2
(POCPA9_2014_v15n1_343_008) 2010; 31
(POCPA9_2014_v15n1_343_025) 2013; 8
(POCPA9_2014_v15n1_343_018) 2008; 17
(POCPA9_2014_v15n1_343_024) 2000; 19
References_xml – volume: 13
  start-page: 117
  year: 2011
  ident: POCPA9_2014_v15n1_343_022
  publication-title: HPB (Oxford)
  doi: 10.1111/j.1477-2574.2010.00255.x
– volume: 30
  start-page: 233
  year: 2013
  ident: POCPA9_2014_v15n1_343_007
  publication-title: Dig Surg
  doi: 10.1159/000353133
– volume: 18
  start-page: 50
  year: 1989
  ident: POCPA9_2014_v15n1_343_011
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/18.1.50
– volume: 9
  start-page: 361
  year: 2008
  ident: POCPA9_2014_v15n1_343_021
  publication-title: Clin Lung Cancer
  doi: 10.3816/CLC.2008.n.052
– ident: POCPA9_2014_v15n1_343_002
  doi: 10.7314/APJCP.2012.13.1.187
– volume: 8
  start-page: 2924
  year: 2002
  ident: POCPA9_2014_v15n1_343_020
  publication-title: Clin Cancer Res
– volume: 17
  start-page: 9
  year: 2008
  ident: POCPA9_2014_v15n1_343_018
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0b013e3280145e1b
– volume: 263
  start-page: 526
  year: 1994
  ident: POCPA9_2014_v15n1_343_027
  publication-title: Science
  doi: 10.1126/science.8290962
– volume: 17
  start-page: 1471
  year: 2010
  ident: POCPA9_2014_v15n1_343_005
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-010-0985-4
– volume: 38
  start-page: 805
  year: 2000
  ident: POCPA9_2014_v15n1_343_026
  publication-title: Zhonghua Wai Ke Za Zhi
– volume: 199
  start-page: 432
  year: 2003
  ident: POCPA9_2014_v15n1_343_015
  publication-title: J Pathol
  doi: 10.1002/path.1319
– volume: 93
  start-page: 610
  year: 2006
  ident: POCPA9_2014_v15n1_343_010
  publication-title: J Surg Oncol
  doi: 10.1002/jso.20526
– volume: 31
  start-page: 471
  year: 2010
  ident: POCPA9_2014_v15n1_343_008
  publication-title: Tumour Biol
  doi: 10.1007/s13277-010-0056-2
– volume: 118
  start-page: 1591
  year: 2006
  ident: POCPA9_2014_v15n1_343_017
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21683
– volume: 4
  start-page: 167
  year: 2003
  ident: POCPA9_2014_v15n1_343_014
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(03)01021-0
– volume: 8
  start-page: 63581
  year: 2013
  ident: POCPA9_2014_v15n1_343_025
  publication-title: Plos One
  doi: 10.1371/journal.pone.0063581
– volume: 5
  start-page: 41
  year: 2012
  ident: POCPA9_2014_v15n1_343_006
  publication-title: Gastrointest Cancer Res
– volume: 29
  start-page: 41
  year: 2008
  ident: POCPA9_2014_v15n1_343_009
  publication-title: Tumour Biol
  doi: 10.1159/000132570
– volume: 19
  start-page: 916
  year: 2004
  ident: POCPA9_2014_v15n1_343_019
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2004.03355.x
– volume: 71
  start-page: 97
  year: 2005
  ident: POCPA9_2014_v15n1_343_023
  publication-title: Digestion
  doi: 10.1159/000084525
– volume: 2
  start-page: 8
  year: 2013
  ident: POCPA9_2014_v15n1_343_001
  publication-title: Clin Transl Med
  doi: 10.1186/2001-1326-2-8
– volume: 250
  start-page: 2323
  year: 1983
  ident: POCPA9_2014_v15n1_343_004
  publication-title: JAMA
  doi: 10.1001/jama.1983.03340170049027
– volume: 46
  start-page: 1145
  year: 2001
  ident: POCPA9_2014_v15n1_343_016
  publication-title: Dig Dis Sci
  doi: 10.1023/A:1010652105532
– volume: 59
  start-page: 328
  year: 2006
  ident: POCPA9_2014_v15n1_343_013
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.2005.027284
– volume: 19
  start-page: 2398
  year: 2000
  ident: POCPA9_2014_v15n1_343_024
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203535
– volume: 18
  start-page: 24
  year: 1999
  ident: POCPA9_2014_v15n1_343_003
  publication-title: Indian J Gastroenterol
– volume: 7
  start-page: 812
  year: 2001
  ident: POCPA9_2014_v15n1_343_012
  publication-title: Clin Cancer Res
SSID ssj0045875
Score 2.0188272
Snippet Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated...
SourceID pubmed
crossref
SourceType Index Database
Enrichment Source
StartPage 343
SubjectTerms Adolescent
Adult
Aged
Female
Gallbladder - metabolism
Gallbladder Neoplasms - genetics
Gallbladder Neoplasms - metabolism
Gallbladder Neoplasms - mortality
Gallbladder Neoplasms - pathology
Gallbladder Neoplasms - surgery
Gallstones - genetics
Gallstones - metabolism
Gene Expression
Humans
India
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Staging
Prognosis
RNA, Messenger - metabolism
Serpins - genetics
Survival Rate
Young Adult
Title Elevated Expression of Maspin mRNA as a Predictor of Survival in Stage II and III Gallbladder Cancer Cases
URI https://www.ncbi.nlm.nih.gov/pubmed/24528054
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2476-762X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0045875
  issn: 1513-7368
  databaseCode: DOA
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBayDhh2GfZe94IOu2XObEvy49gF2eoWCYqiBXozJD9aB64bJE4w5C_tT460bNXtimLdxQosibDNDyTFfKII-QIeQ4Kj4RaGxxZPmWuFIlWWtHMWBJmb6B1y05m3f8oPzsTZYPC7x1pa12qUbO_cV_I_WoV7oFfcJfsAzRqhcAN-g37hChqG6z_peFJmG4kh4-RXy2etNKVltSiq4eXxbA-PkZHIs0gLzM43W1TWYB02Ta0NDDXPs2EUaVYwtD9lWaoSrdFyOEZAYLNqeYZdsdpm32XL5uuXnkj0hEVbFQpxhWnHo4Ox2UT2XZ5faF7AodwUtfEJh3J7qc_Pliv8U0FuTdexnOvUdQnmp8dGqNKlzgmri2Je1P30hcN76YvW4jrM8pk-W8eYZPEX9LR9ZbqmU-uqmS7WedsL-MzhWI0CXw_Je3zkiJEzMnP7Nbdv-ULDUIS1EYqJGyExCokdETsxCHlEHru-57nd-l27fS6CpqqzeR9d4gqFfLvjSW6EQTcWNE1gc_KcPGtXJHRPw-sFGWTVS_Jk2nIuXpF5hzJ6jTJ6lVONMoooo3JFJTUow94OZRSGNCijUURBZ9BEtIcyqlFGG5S9Jqc_Jifjfas9ocNKmLBri8N3cBhPlJeFvkjCPFQ8Y24eeAJsgJBJzlnu-RD2NucWKM_2JeNKBrZQygGH8obsVFdV9o5QL0zzBDrAcQcc7IS0FeeZdL08526WO7vE7T5YnLTl6_EUlTK-R1W75KuZtNDVW-4f_lZrwgxGXgI8LH__MEEfyNNrrH8kO_VynX2C4LVWnxvQwHV2NP0Dr-aSIw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+Expression+of+Maspin+mRNA+as+a+Predictor+of+Survival+in+Stage+II+and+III+Gallbladder+Cancer+Cases&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Baghel%2C+Kavita&rft.au=Kazmi%2C+Hasan+Raza&rft.au=Raj%2C+Saloni&rft.au=Chandra%2C+Abhijit&rft.date=2014-01-01&rft.issn=1513-7368&rft.volume=15&rft.issue=1&rft.spage=343&rft.epage=347&rft_id=info:doi/10.7314%2FAPJCP.2014.15.1.343&rft.externalDBID=n%2Fa&rft.externalDocID=10_7314_APJCP_2014_15_1_343
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon